NRx Pharmaceuticals, Inc.
NRXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,126 | -$30,150 | -$39,754 | -$93,063 |
| Dep. & Amort. | $5 | $5 | $4 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $486 | $387 | $3,628 | $7,785 |
| Change in WC | $5,291 | $5,164 | $699 | -$4,898 |
| Other Non-Cash | $8,707 | $2,937 | -$4,332 | $52,471 |
| Operating Cash Flow | -$10,637 | -$21,657 | -$39,755 | -$37,703 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$3 | -$10 | -$7 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$3 | -$10 | -$7 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,496 | -$3,092 | $9,502 | -$1,276 |
| Stock Issued | $5,911 | $8,122 | $22,702 | $36,983 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,070 | $1,171 | $10 | $27,749 |
| Financing Cash Flow | $7,485 | $6,201 | $32,214 | $63,456 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,152 | -$15,459 | -$7,551 | $25,746 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,595 | $20,054 | $27,605 | $1,859 |
| End Cash | $1,443 | $4,595 | $20,054 | $27,605 |
| Free Cash Flow | -$10,637 | -$21,660 | -$39,765 | -$37,710 |